Revamped Hudson 1.0 Nets HB Record Quarter

corcovado 88

FOR IMMEDIATE RELEASE

Record sales of Haas-Bioroid's newly revamped "Hudson 1.0", an intrusion countermeasure, led the engineering giant to its best quarter since the release of Eli 1.0. Haas-Bioroid (NYSE: H) earned 2 cents per share on sales of 14.6 billion. Analysts were expecting a small loss for the quarter.

Hudson 1.0 had been pulled from the market for several months as the firm re-engineered the widely unpopular product. The re-engineering project failed and was canceled, and HB subsequently developed an entirely new product and released it under the familiar umbrella of the Hudson brand.

Dr Haas is confident that shareholder activists will now be patient as the firm continues work on the long overdue Janus 2.0. "The ICE we now know as Hudson 1.0 is, mark my words, nothing like its useless predecessor."

1 comments
22 Apr 2016 FarCryFromHuman

Loving the fiction, but I'm not sure about the interaction between Hudson 1.0 and Industrial Genomics. I'm pretty sure when the runner hits archives all cards are flipped, regardless of how many cards are accessed. The runner then gets to choose which card to access.